Parkinson's breakthrough? stem cells show promise in early trial
Disease control
Completed
This early-phase trial tested a new stem cell treatment for Parkinson's disease in 12 people who had been diagnosed at least 5 years earlier. The treatment uses dopamine-producing cells made from embryonic stem cells, injected into the brain. The main goal was to check safety, bu…
Phase: PHASE1, PHASE2 • Sponsor: S.Biomedics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC